Skip to main content

Leadership History

Elevance Health: CEO History

4 leaders · 2013 to present

Who is the CEO of Elevance Health?

Gail K. Boudreaux is the CEO of Elevance Health, in the role since 2017. The first chief executive was Joseph Swedish, from 2013.

Current CEO
Gail K. Boudreaux (since 2017)
First CEO
Joseph Swedish (2013)
Leaders documented
4
Founded
1944
NameRoleFromToYears in role
Mark KayeExecutive Vice President and Chief Financial Officer2024Present2
Peter D. HaytaianExecutive Vice President and President, Carelon2022Present4
Gail BoudreauxPresident and CEO2017Present9
Joseph SwedishFormer President and CEO201320174
Who was CEO of Elevance Health before Gail Boudreaux?
Joseph Swedish was CEO of Elevance Health from 2013 to 2017, before Gail Boudreaux took over in 2017.

Company Overview

Elevance Health is one of the largest U.S. health insurers by revenue, with roughly 45 million medical members and about 104 million consumers served across its businesses. It sells Anthem Blue Cross and Blue Shield plans in 14 states, Wellpoint government plans in others, and pharmacy and health services through Carelon. The company is headquartered in Indianapolis, Indiana.

Elevance makes money in two ways. First, its Health Benefits segment collects premiums from employers, individuals and government programs and pays members' medical claims; profit depends on keeping the benefit expense ratio (89.7% in Q2 2026) below premium levels and on fees for administering self-funded employer plans. Second, Carelon earns pharmacy and services revenue: CarelonRx manages prescription benefits and dispenses specialty drugs, while Carelon Services sells behavioral health, home-based care and risk-based care management, increasingly to outside health plans as well as Elevance's own members. Carelon produced $19.2B of operating revenue and $0.9B of operating gain in Q2 2026.

Mark Kaye

Executive Vice President and Chief Financial Officer

2024 – Present

2 years (current)

Key Decisions & Impact

Kaye manages the incredibly complex capital allocation strategy, aggressively utilizing massive stock buybacks while defending the company's highly scrutinized Medicare Advantage margins from federal cuts.

Legacy

Appointed CFO in 2023, he steers the financial operations of the second-largest health insurer in America during a period of intense regulatory pressure on pharmacy benefit managers (PBMs).

Peter D. Haytaian

Executive Vice President and President, Carelon

2022 – Present

4 years (current)

Key Decisions & Impact

Haytaian orchestrated the massive, highly strategic launch of Carelon, Elevance's healthcare services division, aggressively attempting to replicate UnitedHealth's highly lucrative Optum model.

Legacy

As President of Carelon, he oversees the company's absolute highest-growth segment, directly managing the incredibly controversial PBM (CarelonRx) that negotiates drug prices for millions of Americans.

Gail Boudreaux

President and CEO

2017 – Present

9 years (current)

Key Decisions & Impact

Renamed Anthem as Elevance Health in 2022, built Carelon into a segment producing about $19B of quarterly revenue, and in 2025 to 2026 shifted to margin repair by exiting standalone Part D plans and some Medicaid markets.

Legacy

Under Boudreaux, revenue grew to $199.1B in FY2025. In July 2026 she bought about $1M of Elevance stock after the company raised its 2026 guidance.

Joseph Swedish

Former President and CEO

2013 – 2017

4 years

Key Decisions & Impact

Led the company through the Affordable Care Act exchange rollout, renamed WellPoint as Anthem in 2014, and pursued the $54B Cigna merger that courts blocked in 2017.

Legacy

His tenure ended after the failed Cigna deal, with the company pivoting to organic growth and services under his successor.

Challenges & Strategic Context

Elevated medical cost trend in Medicaid and Medicare Advantage, membership attrition in Medicaid and ACA plans, Medicare Advantage star-rating and rate pressure, scrutiny of prior authorization and pharmacy benefit managers, and a share price that fell sharply from its 2024 highs.

Elevance Health CEO and Leadership FAQ

Who is Gail K. Boudreaux and what are her major achievements as CEO of Elevance Health?

Gail K. Boudreaux became CEO of Anthem in November 2017. She renamed the company Elevance Health in 2022, built Carelon, and led revenue to $199.1B in FY2025.

Who was Joseph Swedish and what was his tenure as CEO from 2013 to 2017?

Joseph Swedish served as CEO of WellPoint/Anthem from 2013 to 2017, having previously led Trinity Health. Swedish renamed the company Anthem, Inc. in 2014, expanded ACA exchange participation, and led the $54B Cigna merger attempt.

Who was Angela Braly and what was her role as CEO from 2007 to 2012?

Angela Braly served as CEO of WellPoint from 2007 to 2012, steering the company through the creation and passage of the federal Affordable Care Act (ACA) in 2010 and expanding commercial employer health networks.

Who was Larry Glasscock and what was his legacy as CEO from 1999 to 2007?

Larry Glasscock was the architect who led Anthem's 2001 Initial Public Offering on the NYSE and completed the transformative $16.5 billion merger with California-based WellPoint Health Networks in 2004, creating the nation's largest health insurer.

Who are the key executive leaders on Elevance Health's management team?

Key executives include CFO Mark Kaye, Carelon president Peter Haytaian, and chief legal officer Blair Todt.

Who is the CEO of Elevance Health?

Gail Boudreaux serves as CEO. She took over in 2017 and executed a massive strategic shift, officially changing the company name from Anthem to Elevance Health in 2022 to signal that they were no longer just an insurance company, but a massive holistic "health services" provider.

Related Leadership Timelines

Compare executive leadership tenures and strategic transitions

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.